Psychedelic Decriminalization Bill Passes First Hurdle in California Senate
1.5 min readPublished On: April 6th, 2021By News Team
SACRAMENTO – California State Senator Scott Wiener announced earlier today that his legislation to decriminalize psychedelics (#SB519) just passed the Senate Public Safety Committee on a 4-1 vote.
The Senator said on Twitter: ‘’Our legislation to decriminalize psychedelics (#SB519) just passed the Senate Public Safety Committee on a 4-1 vote. Psychedelics have so much promise for people’s health & well-being. We need to move away from a drug criminalization model & toward a health approach.‘’
Senate Bill 519, would decriminalize the use and possession of psilocybin — the hallucinogen in magic mushrooms — psilocyn, 3,4-methylenedioxymethamphetamine (MDMA a.k.a. molly or ecstasy), lysergic acid diethylamide (LSD), ketamine, dimethyltryptamine (DMT), ibogaine, and mescaline.
Similarly to a previous law signed by former Governor Jerry Brown in 2018 that expunged Cannabis convictions from Californians’ records, Wiener’s bill would also expunge previous convictions for possession or use of psychedelic drugs.
“Let’s embrace science and move past the failed war on drugs,” Wiener said in a Thursday tweet announcing the bill. “Drug use is a health issue, not a criminal issue. And, psychedelics have tremendous health benefits.”
(Pictured: Senator Scott Weiner)
Wiener previously tweeted ‘These drugs have been shown to have medicinal value treating depression, PTSD and other conditions.” And, he added, “There’s strong support for ending the failed War on Drugs, which criminalizes communities of color and those suffering from addiction.”
SB 519 follows on similar moves by Oregon, the city of Denver, and the District of Colombia to decriminalize psychedelics. And Oakland City Council voted in 2019 to decriminalize psychedelics that come from plants — like mushrooms, ayahuasca, and peyote. Wiener’s California bill excludes peyote because of its status as a threatened species.
After this stage of Public Safety Committee’s approval, the legislation next heads to the Senate Health Committee.
Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
BOCA RATON, Fla. - ACS Laboratory, hemp and cannabis testing facility in the eastern U.S., has developed the THCOa Safety Bundle Test, a testing panel to test for THC-O Acetate (THCOa), acetic anhydride and other ...
ROXBORO, N.C. - Open Book Extracts (OBX), a cGMP-certified manufacturer and distributor of the industry's quality cannabinoid ingredients and finished products, announced the addition of Tony Reeves and Tony Scanlan to its European sales and ...
WAKEFIELD, Mass. - Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF), an international provider of consumer products in cannabis, announced the completion of its previously announced acquisition of Bloom Dispensaries, a single state cannabis operator ...
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more